ALKS
ALKS
NASDAQ · Biotechnology

Alkermes Plc

$49.17
+0.80 (+1.65%)
As of Aug 8, 1:22 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.48B
Net Income
241.77M
Gross Margin
86.7%
Profit Margin
16.4%
Rev Growth
+9.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 86.7% 86.7% 61.4% 61.4%
Operating Margin 17.2% 15.5% 15.6% 13.8%
Profit Margin 16.4% 15.6% 14.1% 13.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.48B 1.34B 1.89B 1.59B
Gross Profit 1.28B 1.16B 1.16B 979.55M
Operating Income 254.12M 208.10M 295.17M 220.02M
Net Income 241.77M 197.99M 267.01M 214.03M
Gross Margin 86.7% 86.7% 61.4% 61.4%
Operating Margin 17.2% 15.5% 15.6% 13.8%
Profit Margin 16.4% 15.6% 14.1% 13.4%
Rev Growth +9.9% +9.9% +6.3% -8.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 803.02M 723.95M
Total Equity 3.18B 3.20B
D/E Ratio 0.25 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 259.68M 224.47M 438.15M 351.76M
Free Cash Flow 233.31M 225.75M